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Abstract: Semaphorins were originally identiﬁed as axon guidance cues involved in the
development of the nervous system. In recent years, it is emerging that they also participate in
various biological systems, including physiological and pathological processes. In this review, we
primarily focus on our cumulative ﬁndings for the role of semaphorins and their receptors in the
regulation of the immune system, while also summarizing recent progress in the context of
cardiovascular system.
Keywords: Semaphorin, immune cell interactions, cardiac morphogenesis, plexins
1. Introduction
Cumulative ﬁndings indicate that the nervous
and immune systems have considerable overlap and
links.1) For example, some axon guidance molecules,
such as slits and ephrins, have been shown to regulate
immune cell migration.2),3) In addition, T-cell-anti-
gen-presenting cell contact sites, the so-called ‘im-
munological synapse’, are structurally similar to the
‘neurological synapse’ that connects pairs of neurons.
These shared molecules and interactions play critical
roles in inducing proper immune responses.
Semaphorins were named for properties that are
analogous to the system of ﬂags and lights that is
used in rail and maritime communication. They were
initially identiﬁed as repulsive axon guidance factors
that direct neuronal axons to their appropriate
targets.4) To date, more than 20 types of semaphorins
have been identiﬁed, and they have diverse functions
in many physiological processes, including cardio-
genesis,5) angiogenesis,6) vasculogenesis,7) tumor
metastasis,8) osteoclastogenesis,9) and immune regu-
lation.10) We isolated the cDNA of Sema4D through
the search for CD40 (an immune co-stimulatory
molecule)-inducible genes by subtractive PCR-clon-
ing. In addition, we isolated the cDNA of Sema6D
from the cDNA library of the heart by PCR-cloning
using degenerative primers. The identiﬁcation of
Sema4D and Sema6D has clariﬁed the important
roles of the semaphorin family in the immune and
cardiac systems, respectively. Here, we review the
pleiotropic functions of semaphorins, primarily focus-
ing on their roles in immune responses and cardiac
morphogenesis.
2. Semaphorins and their receptors
Semaphorins are secreted and membrane-asso-
ciated proteins that are characterized by a conserved
extracellular amino-terminal ‘Sema’ domain. Based
on their C-terminal structures, this diverse group of
proteins has been further divided into eight sub-
classes.11) Semaphorins in classes I (invertebrate) and
IV–VII are membrane-associated, whereas those
in classes II (invertebrate), III, and VIII (virally
encoded) are secreted. Two groups of proteins,
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©2010 The Japan Academyplexins and neuropilins (NPs), have been identiﬁed as
the primary semaphorin receptors.12)–14) Most mem-
brane-bound semaphorins directly bind plexins,
whereas class III semaphorins require NPs as obligate
coreceptors. However, increasing evidence has shown
that semaphorin receptor usage is more complex than
previously thought.15) For example, Sema3E signals
independently of NPs through plexin-D1,7) while
Sema7A uses integrins to exert its functions in both
the nervous and immune systems.16),17) In addition,
two molecules unrelated to plexins and NPs, CD7218)
and T-cell immunoglobulin and mucin domain
containing protein 2 (TIM-2),19) functionally interact
with Sema4D and Sema4A, respectively, in the
immune system (Fig. 1).
Plexins are canonical semaphorin receptors that
have large cytoplasmic domains. In the nervous
system, plexin-mediated signals have been shown to
exert diverse neural functions by regulating GTPase
activities and cytoplasmic/receptor-type protein
kinases.20) These signals are also involved in integ-
rin-mediated attachment.21)–23) Of note, plexins can
associate with diﬀerent co-receptors in distinct
tissues to allow semaphorins to exert pleiotropic
functions. For instance, plexin-A1 is associated
with the tyrosine kinase receptors oﬀ-track (OTK)
and vascular endothelial growth factor receptor 2
(VEGFR2) in heart morphogenesis.24) In another
context, plexin-A1 forms a receptor complex with
triggering receptor expressed on myeloid cell
(TREM)-2/DNAX-activating protein 12 (DAP12)
during osteoclastogenesis.9) Furthermore, plexin-B1
has been shown to associate with the receptor
tyrosine kinases Met and ErbB2, inducing invasive
growth of epithelial cells.25),26) These observations
provide insight into the diversity of semaphorin
functions (Fig. 1).
3. Immune semaphorins
(1) Sema4D: a semaphorin involved in B
cell/dendritic cell (DC) activation (Fig. 2a).
Sema4D, also known as CD100, is the ﬁrst sema-
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Fig. 1. Representative semaphorins and their receptors. Among the eight subclasses of semaphorins, class I and II semaphorins are found
in invertebrates (not shown in ﬁgure) and class III–VII are vertebrate semaphorins. Classes II and III and viral semaphorins are
secreted, whereas class IV–VI are transmembrane. Class VII represents GPI-anchored proteins. Sema3A directly binds NP-1 and
associates with plexin-A1, resulting in inducing plexin-A-mediated signals. Although Sema4D binds to plexin-B1 in neurons, plexin-
B1 couples with Met in epithelial cells and induces Sema4D-mediated cell outgrowth. In the immune system, Sema4D binds to CD72,
which promotes B cell and DC activation. Sema4A recognizes plexin-B and D1 in the non-immune systems but uses TIM-2 as a
receptor for T cell activation in the immune system. During cardiogenesis, plexin-A1 associates with OTK or VEGFR2 at distinct
sites. However, plexin-A1 forms a receptor complex with TREM-2-DAP12, which is critical for DC activation and osteoclastogenesis.
Sema7A has two types of receptors: ,1-1 integrin for macrophage activation and plexin-C1 for inhibition of cell adhesion. Viral
semaphorin A39R also recognizes plexin-C1 and modulates dendritic cell function.
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were identiﬁed. In the immune system, abundant
expression of Sema4D is observed in resting T cells.
The basal expression of Sema4D in B cells and DCs is
very low, but protein levels are considerably higher
following cellular activation.18),27) Sema4D promotes
B cell activation in the context of proliferation and
antibody production. Plexin-B1 and CD72 have been
identiﬁed as Sema4D receptors in the nervous and
immune systems, respectively.14),18),22) CD72 contains
two immunoreceptor tyrosine-based inhibitory motifs
(ITIM) in its cytoplasmic domain,28) and is known to
function as a negative regulator of B cells through the
recruitment of the tyrosine phosphatase SHP-1 to
its phosphorylated ITIM.18) Ligation of Sema4D to
CD72 induces dissociation of SHP-1, resulting in B
cell activation (Fig. 2a). Consistently, Sema4D-deﬁ-
cient mice display impaired antibody production,
implicating Sema4D in B cell activation. In addition
to its involvement in B-cell responses, Sema4D is
involved in T cell activation by promoting the activa-
tion and maturation of DCs. In fact, Sema4D-
deﬁcient mice display impaired generation of anti-
gen-speciﬁc T cells.18),27) Although Sema4D is a
transmembrane protein, its extracellular region is
proteolytically cleaved from the surface of activated
lymphocytes in a metalloprotease-dependent proc-
ess.29) Sema4D is also cleaved from the surface of
platelets by the metalloprotease ADAM17.30) Ele-
vated levels of soluble Sema4D protein are detectable
in the culture supernatants of activated lymphocytes
and in the sera of immunized and autoimmune
mice.29)
(2) Sema4A: a semaphorin involved in both
T cell activation and diﬀerentiation. Sema4A is
another class IV semaphorin. In the immune system,
Sema4A is constitutively expressed on DCs.19) The
expression of Sema4A is also detectable in activated
T cells and T helper type 1 (Th1)-polarized cells. DC-
derived Sema4A and T cell-derived Sema4A play
diﬀerent roles during the course of T cell-mediated
immunity; in particular, DC-derived Sema4A is
crucial for antigen-speciﬁc T cell priming, whereas
T cell-derived Sema4A is involved in helper T cell
diﬀerentiation31) (Fig. 2b). Indeed, the critical in-
volvement of Sema4A in the diﬀerentiation of helper
T cells has been demonstrated by the phenotypes of
Sema4A-deﬁcient mice. Sema4A deﬁcient mice show
impaired responses to heat-killed Propionibacterium
acnes, a Th1-inducing agent. In contrast, these mice
show enhanced T helper type 2 (Th2) responses
against infection of Nippostrongylus brasiliensis,a
Th2-inducing intestinal nematode.31) Furthermore,
Sema4A-deﬁcient mice on a Th2-prone BALB/c
background spontaneously develop atopic dermatitis
(T.M. unpublished data), indicating that Sema4A is
involved in the regulation of Th1/Th2 development.
Several lines of evidence support a role of TIM-2,
which is induced on activated T cells, as a functional
receptor for Sema4A.19) The expression of TIM-2 is
preferentially upregulated on T cells during Th2
diﬀerentiation. Administration of recombinant TIM-
2 protein suppresses the development of experimental
autoimmune encephalomyelitis (EAE) is suitable
mice immunized with proteolipid protein-derived
peptide by inhibiting the generation of Th1 cells.32)
Furthermore, TIM-2-deﬁcient mice show exacerbated
lung inﬂammation accompanied by dysregulated Th2
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Fig. 2. Semaphorins in immune cell interactions. Semaphorins
are involved in various phases of immune cell responses.
(a) During T-cell-mediated B-cell activation, engagement of
CD72 by Sema4D induces dephosphorylation of CD72 and
dissociation from SHP-1, which results in enhancement of BCR
signals. Sema4D can also be cleaved proteolytically and function
as a soluble form in an autocrine/paracrine manner. (b) Sema6D
on T cells can activate DCs through plexin-A1. Sema4A on
DCs binds to TIM-2 and activates T cells. (c) T-cell-mediated
inﬂammatory responses require antigen–MHC class II–TCR
interaction and CD40L–CD40 signals. However, the interaction
between Sema7A and ,1-1 integrin is also critical for activation
of inﬂammatory cells such as macrophages.
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interactions negatively regulate Th2 responses. How-
ever, there are some phenotypic diﬀerences between
Sema4A-deﬁcient and TIM-2-deﬁcient mice. For
example, T cells from TIM-2-deﬁcient mice but not
from Sema4A-deﬁcient mice show enhanced basal
proliferation. This observation raises the possibility
that Sema4A and/or TIM-2 have other binding
partners. Indeed, T cells express members of the
plexin-B family and plexin-D1, both of which have
Sema4A-binding activities.34)
(3) Sema6D and plexin-A1: an interaction
involved in the T cell-dendritic cell interface and
osteoclastogenesis. Plexins are the canonical/
primary semaphorin receptors during the develop-
ment of the nervous and cardiovascular systems.
Class III semaphorins bind a receptor complex
formed by plexin-A1 and NP-1. Additionally, plexin-
A1 serves as a direct binding receptor for the class VI
semaphorins, Sema6C and Sema6D.24),35) In the
immune system, plexin-A1 is speciﬁcally expressed
by DCs.36) The function of plexin-A1 in DCs has been
shown using RNA interference and by analysis of
plexin-A1-deﬁcient mice.9),36) ‘Knockdown’ of plexin-
A1 in DCs by short hairpin RNA impairs their ability
to activate T cells in vitro and in vivo. In addition,
plexin-A1-deﬁcient DCs are poor at stimulating
antigen-speciﬁc T cells.36) In vivo, plexin-A1-deﬁcient
mice show impaired T cell-priming.9) These observa-
tions indicate that plexin-A1 expression in DCs is
required for the initial activation and eﬃcient
generation of antigen-speciﬁc T cells. It is worthy of
note that plexin-A1-deﬁcient mice develop osteopet-
rosis as a result of decreased bone resorption due to
defective osteoclastogenesis.9) Sema6D was suggested
to be a ligand for plexin-A1. Indeed, recombinant
Sema6D protein binds to and activates DCs, and
this activity is profoundly attenuated in plexin-A1-
deﬁcient DCs. These observations suggest that
Sema6D-expression on T cells is involved in DC-
activation. The expression of Sema6D is also
observed in osteoclasts. Recombinant Sema6D pro-
tein enhances in vitro osteoclastogenesis, suggesting
that Sema6D and plexin-A1 might function in
osteoclastogenesis in an osteoclast-autonomous man-
ner. Plexin-A1 forms a receptor complex with
TREM-2 and the adaptor molecule DAP12 in DCs
and osteoclasts.9) Interestingly, DAP12-deﬁcient
mice show impaired T cell responses and develop
osteopetrosis,37) and genetic mutations in human
DAP12 or TREM-2 result in a bone fracture
syndrome called Nasu-Hakola disease,38) supporting
the idea that plexin-A1 physiologically associates
with the TREM-2/DAP12 complex.
(4) Sema7A: a semaphorin involved in in-
ﬂammatory responses. Sema7A, also known as
CD108, is a membrane-associated GPI-anchored
protein.39) In the nervous system, Sema7A has been
shown to promote olfactory bulb axon outgrowth and
is required for the proper formation of the lateral
olfactory tract during embryonic development.16)
Plexin-C1 was initially identiﬁed as a receptor for
Sema7A.14) However, in its Sema domain, Sema7A
contains an arginine–glycine–aspartate sequence that
is a well conserved integrin-binding motif, and it
exerts its function through -1 integrin, not through
plexin-C1.16) In the immune system, the expression of
Sema7A is induced on activated T cells, and it is
involved in T cell-mediated inﬂammatory immune
responses.17) Recombinant Sema7A protein stimu-
lates monocytes/macrophages through ,1-1 integ-
rin, also known as very late antigen-1, inducing the
production of proinﬂammatory cytokines17) (Fig. 2c).
Consistently, Sema7A-deﬁcient mice are resistant to
the development of inﬂammation, including hapten-
induced contact hypersensitivity and experimental
autoimmune EAE.17) These observations indicate
that interactions between Sema7A and ,1-1 integrin
are crucial for T cell-mediated macrophage activation
at sites of inﬂammation. Plexin-C1 is also expressed
in macrophages; however, recombinant Sema7A
protein induces normal production of proinﬂamma-
tory cytokines in plexin-C1-deﬁcient macrophages
(unpublished data). Therefore, at least for T cell–
macrophage interactions, ,1-1 integrin but not
plexin-C1 seems to be the predominant receptor for
Sema7A, implying that integrin-mediated signaling is
a common mechanism for Sema7A functions in both
the nervous and immune systems.
(5) Sema3A and plexin-A4: a semaphorin
and semaphorin receptor required for negative
regulation of T cell responses. Sema3A was the
ﬁrst semaphorin identiﬁed in vertebrates. Sema3A
directly binds to NP-1, inducing the activation of
plexin-A proteins and the transduction of axon
repulsive signals. Several lines of evidence suggest
that Sema3A also functions in the immune system
(Fig. 1, Table 1). The expression of Sema3A is
detected in activated DCs, T cells, and some tumor
cells. Sema3A inhibits spontaneous monocyte migra-
tion in vitro. In addition, Sema3A suppresses T cell
proliferation by inhibiting actin cytoskeletal reorgan-
ization and downregulating MAPK signaling.40)
Furthermore, Sema3A-deﬁcient T cells exhibit
A. KUMANOGOH and H. KIKUTANI [Vol. 86, 614enhanced in vitro proliferative responses to anti-CD3
antibodies.41) These observations suggest that Sem-
a3A serves as a negative regulator of T cells. Similar
to other plexin-A proteins, plexin-A4 forms a
receptor complex with NP-1 to transduce class III
semaphorin-mediated signaling or directly binds to
Sema6A.42) Plexin-A4-deﬁcient T cells exhibit hyper-
proliferation and enhanced TCR signals upon anti-
CD3 stimulation. Furthermore, plexin-A4-deﬁcient
mice show enhanced T cell priming and exacerbated
T cell-mediated immune responses such as EAE.41)
Therefore, plexin-A4 might interact with Sema3A
in the immune system and this interaction might
negatively regulate T cell responses. However, it
remains unclear how plexin-A4 negatively regulates
T cells and whether other semaphorins are relevant
to plexin-A4-mediated immune responses.
(6) NP-1: a marker for regulatory T cells. As
described above, NP-1 was originally identiﬁed as a
cell surface glycoprotein that acts as a class III
semaphorin receptor. NP-1 is also known as human
DC-speciﬁc antigen (blood DC antigen)-4, a speciﬁc
plasmacytoid DC marker in humans, and was
assigned CD304. In the immune system, the expres-
sion of NP-1 was observed in DCs and T cells.43)
NP-1 is thought to be involved in the initiation of
primary immune responses through a homophilic
interaction at contact sites between T cells and DCs.
In addition, NP-1 has been identiﬁed as a speciﬁc
marker for CD4+CD25+ regulatory T (Treg) cells.44)
Indeed, NP-1 is a member of the group of forkhead
box P3 (Foxp3)-inducible genes, which also includes
CD25, glucocorticoid-induced tumor necrosis factor
receptor-related protein, and cytotoxic T-lymphocyte
Table 1. Immune semaphorins, their receptors and diseases
Semaphorins/
receptors
Expression in
the immune system
Binding partner Immunological activities
Related-neurological
diseases
Sema3A N.D. Plexin A proteins
Neuropilin-1
Inhibition of monocyte migration
Inhibition of T-cell activation
Alzheimer’s disease
Atopic dermatitis
Sema4A Dendritic cells
Acticated-T cells
Th1 cells
Plexin B proteins
Plexin-D1
TIM-2
T-cell activation
Promotion of Th1-diﬀerentiation
EAE
Atopic dermatitis
Sema4D T cells
Activated-B cells
Dendritic cells
Plexin-B1
CD72
B-cell activation
DC-activation
EAE
HAM
Sema5A N.D.
(Oligodendrocytes)
N.D. N.D. Parkinson’s disease
Sema6D T cells
B cells
NK cells
Plexin-A1 DC-activation
Sema7A Acticated-T cells Plexin-C1
Integrin ,1-1
Monocyte/macrophage-activation Contact hypersensitivity
EAE
Neuropilin-1 T cells
Treg cells
Class III semaphorins Alzheimer’s disease
Plexin-A1 Dendritic cells
(Osteoclasts)
Class VI semaphorins DC-activation EAE
Plexin-A4 T cells
Dendritic cells
Macrophages
Class VI semaphorins Inhibition of T-cell activation EAE
Plexin-B1 Class IV semaphorins
TIM-2 Acticated-T cells
Th2 cells
Sema4A T-activation EAE
Airway atopy
CD72 B cells
(Dendritic cells)
Sema4D B-cell activation
DC-activation
Integrin ,1-1 Monocytes
Macrophages
Sema7A Monocyte/macrophage-activation EAE
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suggested that NP-1 in Treg cells contributes to the
long contact between Treg cells and DCs compared
with the shorter contact between naive T cells and
DCs. Treg cells made stable contacts with DCs that
preceded the contact of naive T cells with DCs; this
might lead to the inhibition of T-cell activation
at steady state.45) The ﬁnding that Treg cells are
endowed with the ability to have long interactions
with DCs mediated by NP-1 supports the idea
that NP-1 might contribute to physical interactions
between T cells and DCs.
4. Semaphorins in cardiac morphogenesis
Cumulative ﬁndings also indicate the signiﬁ-
cance of semaphorins in the development of other
organ systems, such as the cardiovascular system, in
which some semaphorins control the migration of
endothelial cells, cardiac myocytes, or their precur-
sors.24),34),46),47)
(1) Sema6D-Plexin-A1 in cardiac morpho-
genesis. One of the best characterized roles of a
semaphorin in cardiac development is that of
Sema6D, which belongs to the class VI transmem-
brane-type semaphorin subfamily. In mice, the
expression of Sema6D is ﬁrst detected in the cardiac
crescent and neural fold of E9 embryos.24) The
roles of Sema6D in the developing heart have been
revealed by a series of studies using the chick embryo
system. Inoculation of transfected cells that release a
large amount of soluble Sema6D into cultured chick
embryos at Hamberger and Hamilton (HH) stage 9
results in enhanced looping of the cardiac tube
and enlargement of the ventricular region. In ovo
inoculation of Sema6D producing cells or recombi-
nant soluble Sema6D into HH stage 29 embryos
results in an expanded ventricular cavity with a
thin myocardial layer and an enlarged endocardial
cushion. In contrast, RNAi-mediated knockdown of
Sema6D inhibits looping of the cardiac tube.24) In
this context, Sema6D signals are largely mediated
through Plexin-A1, which is also expressed in the
embryonic heart. Indeed, RNAi-mediated knock-
down of Plexin-A1 or expression of truncated
Plexin-A1 resulted in shrunken ventricles.24) There-
fore, the Sema6D-Plexin-A1 axis is critically in-
volved in the dynamic remodeling of the cardiac
tube and formation of the ventricle and endocardial
cushion.
(2) Sema6D exerts distinct biological activ-
ities in endothelial cells in diﬀerent regions of the
cardiac tube. Sema6D inhibits the migration of
outgrowing cells from the ventricle segment. In
contrast, Sema6D promotes the migration of out-
growing cells from the conotruncal and atrio-
ventricular valve segments, which later fuse to form
the endocardial cushion. These biological activities
of Sema6D appear to be mediated through Plexin-
A1, as they are abrogated by RNAi-mediated
knockdown of Plexin-A1 or expression of truncated
Plexin-A1 in endothelial cells from the ventricle or
conotruncal segments.24) Interestingly, we have
demonstrated that Plexin-A1 forms a complex with
OTK in the endothelial cells of the ventricular
region of the cardiac tube, whereas it forms a
complex with VEGFR2 in endothelial cells of
the conotruncal segments. Further, the Sema6D-
induced migration of endothelial cells is suppressed
both by RNAi against Plexin-A1 and by RNAi
against VEGFR2.24) This diﬀerential association of
Plexin-A1 with additional receptor components
allows Sema6D to exert distinct biological activities
in adjacent regions, which is critical for complex
cardiac morphogenesis.
(3) Reverse signaling of Sema6D in the
cardiac ventricle. Among the semaphorin family
members, class VI semaphorins are unique because of
their relatively long cytoplasmic regions, which may
imply the existence of reverse signaling. Indeed, it has
been reported that the Sema6A cytoplasmic region
can associate with two molecules,48) Abl kinase and
Enabled (Ena), a member of the Ena/VASP family.
Abl kinase and Ena are known to play opposing roles
downstream of drosophila Robo, an axon guidance
receptor for Slit.49) Ena has also been implicated in
reverse signaling of drosophila Sema1a.50) Upon
binding to the ectodomain of Plexin-A1, Abl kinase
is recruited to the cytoplasmic tail of Sema6D and
activated, resulting in phosphorylation of Ena and
dissociation from Sema6D.46) In the case of fate-
mapping studies using myocardial cells, cells carrying
defects in Sema6D reverse signaling arrest in the
compact layer, while expression of constitutively
active Abl kinase enhances the migration of cells
from the compact layer to the trabeculae.46) Thus,
class VI semaphorins transduce reverse signals
through their cytoplasmic domains to regulate bio-
logical output.
5. Semaphorin-mediated signals
in endothelial cell migration
As described above, the class III semaphorins
exert pleiotropic functions through NP-1/Plexin-A
receptor complexes, which regulate small GTPases
A. KUMANOGOH and H. KIKUTANI [Vol. 86, 616and integrins.21),51),52) However, the molecular mech-
anisms underlying this regulation/integration have
remained unclear.
We have determined that the FERM domain-
containing guanine nucleotide exchange factor
(GEF) FARP2 functions as an immediate down-
stream signal transducer of the Plexin-A1-NP-1
receptor complex in Sema3A-mediated repulsion of
neuronal axons.23) Sema3A-induced dissociation of
FARP2 from Plexin-A1 and activation of its Rac-
GEF activity triggers a series of biochemical events,
including Rac activation and the binding of Rnd1, a
member of the Rho GTPase family, to Plexin-A1.
This binding stimulates the GAP activity of Plexin-
A1 for R-Ras, a member of the Ras GTPase family.
The down-regulation of R-Ras leads to the cyto-
skeletal disassembly that is critical for Plexin-A1-
mediated growth cone collapse.22) In parallel with
this event, dissolved FARP2 competes with an
isoform of type-1 phosphatidylinositol phosphate
kinase, PIPKI.661, for the FERM domain of talin.
PIP2 generated by PIPKI.661 in association with
talin is important for the stability of integrin-
mediated focal adhesions,53),54) and the inhibition of
PIPKI.661 kinase activity by FARP2 binding down-
regulates integrin function. Thus, semaphorin-Plexin
signaling is involved in cardiac morphogenesis by
regulating cytoskeletal dynamics and cell-matrix
interactions.
6. Perspectives
Accumulating evidence reveals that several
semaphorins and their receptors have multiple bio-
logical activities. These semaphorins form a family of
immunoregulatory molecules, called ‘immune sema-
phorins’ (Fig. 3, Table 1). Indeed, the lack of
semaphorin family proteins results in several immune
disorders, including autoimmune diseases, allergy,
and congenital bone disease. Lack of these proteins
also causes unresponsiveness to physiological immune
responses (Table 1). Therefore, semaphorin family
proteins are at least involved in immunological
homeostasis, based on sophisticated immune cell
communication systems. Furthermore, the pattern-
ing and morphogenesis of the heart, as regulated by
semaphorins and their receptors are discussed in this
review. However, the molecular information available
in this context remains fragmented. To understand
heart development further, we should complete the
deﬁnition of the molecular systems required for its
formation, and then seek the points of integration
between these systems.
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Fig. 3. Involvement of immune semaphorins in various phases of immune responses. In the initial phase of T cell immune responses,
Sema4D and Sema6D expressed by T cells activate DCs through their receptors, CD72 and plexin-A1, respectively. Plexin-A1 is also
involved as a negative regulator. Sema4A expressed on DCs is also involved in T cell priming through its binding partner, TIM-2, of
which expression is induced on activated T cells. Sema4A is required for regulating the diﬀerentiation of Th cells. In contrast, Sema4D
is upregulated on activated T cells and promotes humoral immune responses through the activation of B cells. Diﬀerentiated eﬀector
T cells express Sema7A on their cell surface, and interactions between T cell expressing Sema7A and macrophage expressing ,1-1
integrin induce macrophage activation, resulting in the promotion of inﬂammatory responses. BCR, B cell receptor; MHC, major
histocompatibility complex; TCR, T cell receptor.
Semaphorins and their receptors: Novel features of neural guidance molecules No. 6] 617Several important issues remain to be resolved.
Although semaphorins function to regulate cell
motility and morphology by activating plexins, most
of the immunological studies of semaphorins have
only focused on their costimulatory eﬀects. However,
it is plausible that semaphorins exert their functions
by aﬀecting the cytoskeleton. Further studies are
required to clarify the role of semaphorins in cell-cell
interactions, cell morphology, and dynamics, both in
the immune system and cardiac morphogenesis.
Finally, understanding of semaphorins and their
receptors should allow pharmacological modulation
of their functions, and may lead to the identiﬁcation
of potential therapeutic targets for several human
diseases.
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